We created a mathematical model to investigate the treatment impact and economic implications of introducing an antimicrobial resistance point-of-care test (AMR POCT) for gonorrhoea as a way of extending the life of current last-line treatments. The introduction of AMR POCT could allow clinicians to discern between the majority of gonorrhoea-positive patients with strains that could be treated with older, previously abandoned first-line treatments, and those requiring our current last-line dual therapy. Such tests could extend the useful life of dual ceftriaxone and azithromycin therapy, thus pushing back the time when gonorrhoea may become untreatable.
Fatal error: Uncaught Error: Call to undefined function get_field() in /home/u572422322/staging.aquariusph.com/web/app/themes/hello-elementor-child/single-jetpack-portfolio.php:33 Stack trace: #0 /home/u572422322/staging.aquariusph.com/web/wp/wp-includes/template-loader.php(106): include() #1 /home/u572422322/staging.aquariusph.com/web/wp/wp-blog-header.php(19): require_once('/home/u57242232...') #2 /home/u572422322/staging.aquariusph.com/web/index.php(6): require('/home/u57242232...') #3 {main} thrown in /home/u572422322/staging.aquariusph.com/web/app/themes/hello-elementor-child/single-jetpack-portfolio.php on line 33